State-owned Holdipharma targets EGP 18bn in revenues for FY2025/2026
His remarks came while chairing the General Assembly meeting of the Holding Company for Pharmaceuticals (Holdipharma) to approve the budget plan for the 2025/2026 fiscal year. During the meeting, Ashraf El-Khouly, CEO and Managing Director of Holdipharma, presented the board's report, which included the draft budget for the coming fiscal year. The plan targets consolidated revenues of EGP 18bn, a 131% increase compared to 2023/2024, and net profits of EGP 3.4bn—up 343%. The report also noted the growth in the market value of the group's listed companies.
The meeting, attended by Board Chair Ahmed Hegazy, members of the General Assembly, and representatives of the Central Auditing Organisation, marked the final approval of all holding companies' and subsidiaries' budgets for the new fiscal year.
Minister El-Shimy explained that the ministry is working to localise and deepen pharmaceutical manufacturing, transfer and apply the latest global production technologies, and enhance product quality to strengthen competitiveness in local, regional, and international markets. Development plans include upgrading production lines, increasing manufacturing capacity, adhering to the highest standards of sustainability, quality, and Good Manufacturing Practice (GMP), ensuring occupational health and safety, and optimising the use of assets, capacities, and resources.
He added that human capital development is central to achieving these targets, through specialised training and qualification programmes that encourage innovation and advance scientific research, alongside fostering partnerships with the private sector both domestically and internationally. These measures aim to increase production and export capacity, and open new markets to bolster the competitiveness of the national industry.
El-Shimy stressed that reforming the financial structures of subsidiary companies is a top priority to ensure sustainable profitability and secure the resources needed for production expansion. He underscored the importance of updating organisational structures and management systems to meet current needs, while accelerating the implementation of the Enterprise Resource Planning (ERP) system to improve operational efficiency and ensure precise oversight of resources and production.
The presentation also highlighted major projects and investment opportunities, including the production of biological drugs, insulin and biosimilars, dry powder inhalation tablets, active pharmaceutical ingredients (APIs), and hormones. It outlined partnerships with leading international companies, such as US-based Dawah, to produce and export products including ampoules, nutritional supplements, sterile injections, and sterile ophthalmic preparations.
El-Shimy concluded by stressing the integration of economic, social, and environmental dimensions to ensure comprehensive sustainability in the company's activities. He called for promoting professional conduct, improving the work environment, and raising performance standards across all administrative and executive levels.
He affirmed that the Ministry of Public Enterprises Sector is moving decisively towards modernising and restructuring its subsidiaries, striking a balance between profitability and sustainability, and enhancing Egypt's competitiveness regionally and globally. Holdipharma, he added, aims to achieve regional leadership in the sector, positioning Egypt as an advanced hub for pharmaceutical production and exports, meeting domestic needs while expanding into international markets.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily News Egypt
27 minutes ago
- Daily News Egypt
Voice index: How Arab singers' fees became dollar-denominated market
In the glittering backstage world of concerts and festivals, the true drama often plays out not on stage but in closed-door negotiations—where a singer's 'price' is agreed upon. This figure, set in a performance contract, is more than a reflection of talent. It represents years of brand building, market demand, and the mood of the entertainment economy. By 2025, performance fees in the Arab music scene have become a fascination for fans and industry watchers alike—functioning almost like an economic index, rising and falling with the same volatility as financial markets. At the top of the chart stands Amr Diab, the unrivalled brand name of Arabic pop. His staying power stems from decades of hits and a finely tuned pricing strategy. According to one major Egyptian event organiser, Diab works with five separate rate cards, adjusting fees according to event type, host profile, location, and personal relationships. Public concerts bring him $200,000–$500,000, while corporate-sponsored shows can reach $1m. Wedding performances in Egypt fetch around EGP 6m, doubling for overseas events. On rare occasions, Diab waives his fee entirely—covering only his band's costs—such as for the wedding of a prominent producer's daughter. This tiered pricing is common among A-list artists, who treat their performances as dynamic commodities rather than fixed offerings. Rates fluctuate depending on audience profile, season, and media exposure. Among female stars, Nancy Ajram and Najwa Karam lead the pack. Ajram commands about $120,000 per concert, rising to $200,000 for exclusive private events. Karam has kept her fee steady for years, resisting market pressure despite speculation. If Ajram's approach is driven by ticket sales, Myriam Fares follows a different path—her fee has remained fixed at $50,000 since 2017, partly due to health-related career pauses. In Egypt, Sherine Abdel Wahab tops the women's list at $125,000 per event, followed by Angham at $80,000. For male performers, Tamer Hosny and Mohamed Hamaki earn $80,000–$100,000, reflecting steady but plateaued demand. Some names, like Saad Lamjarred, have yet to convert fame into premium rates, with his $50,000 ceiling often linked to controversies. Others, such as Majida El Roumi, Ragheb Alama, and George Wassouf, have kept their rates unchanged for over a decade, preferring stability to risk. Industry experts note that a single viral hit can boost a singer's fee by 20–30% within a year, while scandals, illness, or poor publicity can cause instant drops. Event timing, geographic market, audience demographics, live broadcasts, and even stage design can all influence the final figure. Some artists inflate their publicised rates to project prestige, while others accept lower fees in exchange for strategic exposure or entry into new markets. Ultimately, in 2025, a singer's fee is no longer just a payment—it's a tradable certificate of artistic capital. Some secure their value and hold; others gamble for rapid gains. And a few walk the tightrope between favour and profit, aware that in this market, opportunities are fleeting—and often, once lost, gone for good.
Daily News Egypt
27 minutes ago
- Daily News Egypt
MSMEDA, Banque du Caire ink EGP 500m agreements to finance 5,300 micro-enterprises
The Micro, Small, and Medium Enterprise Development Agency (MSMEDA) and Banque du Caire have signed two new contracts worth a total of EGP 500m to finance micro-enterprises across all governorates of Egypt through the bank. The contracts were signed by Mohamed Medhat, Deputy CEO of MSMEDA, and Ayman Khattab, Head of the Financial Institutions Sector at Banque du Caire, in the presence of Basil Rahmy, CEO of MSMEDA, and Hussein Abaza, Managing Director and CEO of the bank. Rahmy stressed the agency's commitment to expanding the financing of micro-enterprises, in line with the directives of the political leadership to strengthen the support and financing system for small and micro-enterprises. He emphasised that such support enables entrepreneurs to develop their businesses, boost productivity, access foreign markets, create more job opportunities for themselves and others, contribute to the national economy, and improve living standards. He explained that the signing of the two new contracts aims to empower micro-projects as one of the most important tools of economic and social development by expanding their financing base. He noted that the contracts will also contribute to achieving financial inclusion by integrating micro-entrepreneurs into the formal economy and facilitating their access to both financial and non-financial services. The MSMEDA CEO added that the agency is keen to offer innovative financing products that meet the needs of various segments of society and improve citizens' quality of life by supporting productive projects. He pointed out that the maximum financing value from these two contracts reaches EGP 500,000 per beneficiary, providing greater flexibility to meet project requirements and expand operations. Rahmy further explained that the first contract aims to support micro-entrepreneurs operating in the informal sector and encourage them to transition into the formal economy. This will be achieved by providing the necessary financing to increase their growth and expansion opportunities while ensuring access to the incentives and facilities offered by the state to formalised projects. The second contract focuses on financing existing micro-projects seeking to develop, expand, renew, or replace equipment, by offering facilitated funding that enables these projects to increase production, raise operational efficiency, and enhance competitiveness in the local market. For his part, Bahaa El-Shafei, Deputy CEO of Banque du Caire, said that the partnership between MSMEDA and the bank has contributed to financing thousands of projects. He confirmed that the new agreements will open the door to further job opportunities and promote sustainable economic and social development. He stressed that Banque du Caire is one of the leading banks in financing micro-enterprises in the Egyptian market, backed by over 20 years of extensive experience in this field. The bank has provided 1.3 million job opportunities and productive projects serving diverse segments, especially youth and women breadwinners. El-Shafei also noted that the bank's distinction in this field stems from its geographic reach, particularly in Upper Egypt, which accounts for about 51% of its microfinance clients. Women account for 35% and youth for 54% of the bank's micro-lending portfolio. He explained that the bank offers a fully integrated range of products and services tailored to the needs of this vital sector, in line with Egypt's Vision 2030 for sustainable development and financial inclusion. Medhat stated that the two contracts target financing approximately 5,300 micro-enterprises distributed across the governorates, with a focus on vulnerable groups, especially women and youth. They will be supported in engaging in formal economic activity through the necessary financing, assistance in completing official paperwork, and streamlining procedures. Khattab stressed that the new agreements with MSMEDA mark an important step in the bank's journey to support micro-entrepreneurs, highlighting the bank's keenness to direct financing towards the most in-need groups nationwide. He also emphasised the importance of integrating these entrepreneurs into the formal economy, enhancing productivity, and boosting capacity. He added that Banque du Caire has a comprehensive system and extensive expertise in offering both financial and non-financial solutions tailored to customer needs, which supports growth and employment opportunities and contributes to achieving the state's targets for financial inclusion and sustainable development. The cooperation between MSMEDA and Banque du Caire began in 2012 and has resulted in financing over 862,000 micro-enterprises with a total value of about EGP 16.5bn. This was achieved through revolving loans worth around EGP 4.3bn, provided by MSMEDA through Banque du Caire branches nationwide, reflecting the depth of integration between state institutions and national banks in supporting and developing the micro-enterprise sector.
Daily News Egypt
28 minutes ago
- Daily News Egypt
Total financing by FRA-regulated entities hits EGP 640.1bn in June 2025
The total financing provided through entities supervised by the Financial Regulatory Authority (FRA)—covering both capital market activities and non-banking financial services—reached EGP 640.1bn in June 2025, according to the Authority's latest monthly report. The report showed that this financing included EGP 334.8bn in equity issuances, EGP 52.5bn from issuances of securities other than shares, EGP 84.4bn in financial leasing contracts, EGP 49.2bn in financing for medium, small, and micro enterprises, EGP 38.1bn in consumer financing, EGP 59bn in factored securities, and EGP 22.1bn in mortgage financing. By the end of June 2025, the value of registrations on movable assets in the Movable Collateral Registry reached EGP 3.7 trillion, while outstanding balances of financing for medium, small, and micro enterprises stood at EGP 84.8bn. The total insurance premiums collected during the period reached EGP 56.8bn, with claims paid by the insurance sector amounting to EGP 29bn. The investments of private insurance funds stood at EGP 13.9bn. According to the FRA, property and liability insurance accounted for EGP 32.3bn of the total insurance premiums, while life insurance and fund formation activities contributed EGP 24.5bn.
